Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2006

01.11.2006

Bypass Surgery Versus Palliative Pancreaticoduodenectomy in Patients with Advanced Ductal Adenocarcinoma of the Pancreatic Head, with an Emphasis on Quality of Life Analyses

verfasst von: B. Schniewind, MD, B. Bestmann, R. Kurdow, J. Tepel, D. Henne-Bruns, F. Faendrich, B. Kremer, T. Kuechler

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

In some centers, palliative resection (PR; partial pancreaticoduodenectomy) is, in selected cases, promoted in preference to double loop bypass (DLB) surgery for advanced pancreatic cancer. This prospective study compares PR with DLB, placing particular focus on patients’ quality of life (QoL).

Methods

From 01/1993 to 09/2004, 167 patients were analyzed in a prospective single center study of palliative surgical treatment of advanced ductal adenocarcinoma of the pancreatic head. Thirty-eight underwent PR and 129 underwent palliative DLB. Patients undergoing DLB were divided into: (1) locally advanced disease (LAD-subgroup; n = 61; 47%) and (2) metastasized disease (MD-subgroup; n = 68; 53%). QoL was assessed using the EORTC QLQ-C30 questionnaire supplemented by a pancreatic cancer specific module. QoL data were collected pre-operatively and for up to 12 months after surgery.

Results

Median survival was 7.0 months (95% CI 4.09; 9.91) in PR patients and 6.0 months (95% CI 5.39; 6.61) in patients who received DLB. Mortality and morbidity were, respectively, 7.8 and 58% for PR, and 2.6 and 42% for DLB. QoL decreased more after PR than after DLB. The DLB-group recovered quicker, reaching pre-operative QoL levels after 3 months, and were less impaired when discharged. The LAD-subgroup and the MD-subgroup presented with equal levels of QoL.

Conclusions

QoL analysis revealed favorable QoL data after DLB. Additionally, the survival rates of the two groups did not differ significantly, but morbidity and mortality rates in the PR group were elevated. Therefore, the use of PR for advanced pancreatic cancer needs to be carefully evaluated.
Literatur
1.
Zurück zum Zitat Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54(1):8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54(1):8–29PubMedCrossRef
2.
Zurück zum Zitat Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82(1):111–5PubMed Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82(1):111–5PubMed
3.
Zurück zum Zitat Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1–7CrossRefPubMed Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1–7CrossRefPubMed
4.
Zurück zum Zitat Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic g astrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230(3):322–8; discussion 328–30CrossRefPubMed Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic g astrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230(3):322–8; discussion 328–30CrossRefPubMed
5.
Zurück zum Zitat Kuriansky J, Saenz A, Astudillo E, et al. Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas. Surg Endosc 2000; 14(2):179–81CrossRefPubMed Kuriansky J, Saenz A, Astudillo E, et al. Simultaneous laparoscopic biliary and retrocolic gastric bypass in patients with unresectable carcinoma of the pancreas. Surg Endosc 2000; 14(2):179–81CrossRefPubMed
6.
Zurück zum Zitat Ouchi K, Sugawara T, Ono H, et al. Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg 1998; 22(4):413–6; discussion 417CrossRefPubMed Ouchi K, Sugawara T, Ono H, et al. Palliative operation for cancer of the head of the pancreas: significance of pancreaticoduodenectomy and intraoperative radiation therapy for survival and quality of life. World J Surg 1998; 22(4):413–6; discussion 417CrossRefPubMed
7.
Zurück zum Zitat Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223(6):718–25; discussion 725–8CrossRefPubMed Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 1996; 223(6):718–25; discussion 725–8CrossRefPubMed
8.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236(3):355–66; discussion 366–8CrossRefPubMed Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236(3):355–66; discussion 366–8CrossRefPubMed
9.
Zurück zum Zitat Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, et al. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005; 92(4):471–7CrossRef Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, et al. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005; 92(4):471–7CrossRef
10.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5):365–76PubMed Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5):365–76PubMed
11.
Zurück zum Zitat Fayers PMAN, Bjordal K, Curran D, Groenvold M. (1999) EORTC QLQ-C30 Scoring manual, 2nd edn. Fayers PMAN, Bjordal K, Curran D, Groenvold M. (1999) EORTC QLQ-C30 Scoring manual, 2nd edn.
12.
Zurück zum Zitat Kuechler T. Quality of life research in oncology. Quality of life and health: Concepts, methods and applications. Vienna: Blackwell Wissenschafts-Verlag (1995) pp 89–96 Kuechler T. Quality of life research in oncology. Quality of life and health: Concepts, methods and applications. Vienna: Blackwell Wissenschafts-Verlag (1995) pp 89–96
13.
Zurück zum Zitat Kuechler T. Evaluation of effects of medical/psychological support on survival and quality of life in patients with gastrointestinal tumors—a prospective, randomised trial. Final report to the German Ministry of Technology and Research (BMFT), 1996 Kuechler T. Evaluation of effects of medical/psychological support on survival and quality of life in patients with gastrointestinal tumors—a prospective, randomised trial. Final report to the German Ministry of Technology and Research (BMFT), 1996
14.
Zurück zum Zitat Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37(11):1345–51CrossRefPubMed Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37(11):1345–51CrossRefPubMed
15.
Zurück zum Zitat Berzon RA. Understanding and using health-related quality of life instruments within clinical research studies. In: Fayers PM, Hays RD, (eds). Quality of life assessment in clinical trials—methods and practice. Oxford: Oxford University Press (2005) Berzon RA. Understanding and using health-related quality of life instruments within clinical research studies. In: Fayers PM, Hays RD, (eds). Quality of life assessment in clinical trials—methods and practice. Oxford: Oxford University Press (2005)
16.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16(1):139–44PubMed Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16(1):139–44PubMed
17.
18.
Zurück zum Zitat Schwarz A, Beger HG. Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials. Int J Pancreatol 2000; 27(1):51–8PubMed Schwarz A, Beger HG. Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials. Int J Pancreatol 2000; 27(1):51–8PubMed
19.
Zurück zum Zitat Nuzzo G, Clemente G, Cadeddu F, Giovannini I. Palliation of unresectable periampullary neoplasms. “surgical” versus “non-surgical” approach. Hepatogastroenterology 2004; 51(59):1282–5PubMed Nuzzo G, Clemente G, Cadeddu F, Giovannini I. Palliation of unresectable periampullary neoplasms. “surgical” versus “non-surgical” approach. Hepatogastroenterology 2004; 51(59):1282–5PubMed
20.
Zurück zum Zitat Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005; 92(5):547–56CrossRefPubMed Seiler CA, Wagner M, Bachmann T, et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 2005; 92(5):547–56CrossRefPubMed
21.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4(6):567–79CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4(6):567–79CrossRefPubMed
22.
Zurück zum Zitat Kremer B, Vogel I, Luttges J, et al. Surgical possibilities for pancreatic cancer: extended resection. Ann Oncol 1999; 10(Suppl 4):252–6CrossRefPubMed Kremer B, Vogel I, Luttges J, et al. Surgical possibilities for pancreatic cancer: extended resection. Ann Oncol 1999; 10(Suppl 4):252–6CrossRefPubMed
23.
Zurück zum Zitat Lillemoe KD. Primary duodenal adenocarcinoma: role for aggressive resection. J Am Coll Surg 1996; 183(2):155–6PubMed Lillemoe KD. Primary duodenal adenocarcinoma: role for aggressive resection. J Am Coll Surg 1996; 183(2):155–6PubMed
24.
Zurück zum Zitat Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238(6):894–902; discussion 902–5PubMed Van Heek NT, De Castro SM, van Eijck CH, et al. The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238(6):894–902; discussion 902–5PubMed
25.
Zurück zum Zitat McLeod RS. Quality of life, nutritional status and gastrointestinal hormone profile following the Whipple procedure. Ann Oncol 1999; 10(Suppl 4):281–4CrossRefPubMed McLeod RS. Quality of life, nutritional status and gastrointestinal hormone profile following the Whipple procedure. Ann Oncol 1999; 10(Suppl 4):281–4CrossRefPubMed
26.
Zurück zum Zitat Huang JJ, Yeo CJ, Sohn TA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231(6):890–8CrossRefPubMed Huang JJ, Yeo CJ, Sohn TA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231(6):890–8CrossRefPubMed
27.
Zurück zum Zitat Kahlke V, Bestmann B, Schmid A, et al. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004; 28(4):369–75CrossRefPubMed Kahlke V, Bestmann B, Schmid A, et al. Palliation of metastatic gastric cancer: impact of preoperative symptoms and the type of operation on survival and quality of life. World J Surg 2004; 28(4):369–75CrossRefPubMed
28.
Zurück zum Zitat Thybusch-Bernhardt A, Schmidt C, Kuchler T, et al. Quality of life following radical surgical treatment of gastric carcinoma. World J Surg 1999; 23(5):503–8CrossRefPubMed Thybusch-Bernhardt A, Schmidt C, Kuchler T, et al. Quality of life following radical surgical treatment of gastric carcinoma. World J Surg 1999; 23(5):503–8CrossRefPubMed
29.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005; 12(2):117–23CrossRefPubMed Schmidt CE, Bestmann B, Kuchler T, et al. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer. Ann Surg Oncol 2005; 12(2):117–23CrossRefPubMed
30.
Zurück zum Zitat Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue—the use of the thentest approach. Acta Oncol 1999; 38(6):709–18CrossRefPubMed Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue—the use of the thentest approach. Acta Oncol 1999; 38(6):709–18CrossRefPubMed
Metadaten
Titel
Bypass Surgery Versus Palliative Pancreaticoduodenectomy in Patients with Advanced Ductal Adenocarcinoma of the Pancreatic Head, with an Emphasis on Quality of Life Analyses
verfasst von
B. Schniewind, MD
B. Bestmann
R. Kurdow
J. Tepel
D. Henne-Bruns
F. Faendrich
B. Kremer
T. Kuechler
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2006
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9172-z

Weitere Artikel der Ausgabe 11/2006

Annals of Surgical Oncology 11/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.